Isoprostane‐8 and GDF‐15 as novel markers of post‐PE syndrome: Relation with prothrombotic factors

Where should patients with acute pulmonary embolism be treated?

(2020) Piotr Pruszczyk et al.   Kardiologia Polska

Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism

(2020) Fredrikus A. Klok et al.   EUROPEAN RESPIRATORY JOURNAL

Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism

(2020) Ellen-Sofie Hansen et al.   BLOOD

Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality risk

(2020) Michał Ząbczyk et al.   Scientific Reports

Galectin-3, GDF-15, and sST2 for the assessment of disease severity and therapy response in patients suffering from inoperable chronic thromboembolic pulmonary hypertension

(2020) Steffen D. Kriechbaum et al.   BIOMARKERS

“The post-pulmonary syndrome - results of echocardiographic driven follow up after acute pulmonary embolism”

(2019) Olga Dzikowska-Diduch et al.   THROMBOSIS RESEARCH

An international study on the feasibility of a standardized combined plasma clot turbidity and lysis assay: communication from the SSC of the ISTH

(2018) M. Pieters et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Late outcomes of pulmonary embolism: The post-PE syndrome

(2018) Akhilesh K. Sista et al.   THROMBOSIS RESEARCH

Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial

(2018) Stefano Barco et al.   Clinical Research in Cardiology

Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians

(2017) Eduardo Vazquez-Garza et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Deep vein thrombosis and pulmonary embolism

(2016) Marcello Di Nisio et al.   LANCET

The Diagnostic Value of Oxidative/Antioxidative Balance Parameters in Venous Thromboembolism

(2015) Guzin Aykal et al.   Clinical Laboratory

Thromboembolic resolution assessed by CT pulmonary angiography after treatment for acute pulmonary embolism

(2015) Lucia J. M. Kroft et al.   THROMBOSIS AND HAEMOSTASIS

Increased Oxidation as an Additional Mechanism Underlying Reduced Clot Permeability and Impaired Fibrinolysis in Type 2 Diabetes

(2015) Anna Lados-Krupa et al.   Journal of Diabetes Research

The post-PE syndrome: a new concept for chronic complications of pulmonary embolism

(2014) F.A. Klok et al.   BLOOD REVIEWS

Functional impact of oxidative posttranslational modifications on fibrinogen and fibrin clots

(2013) Marissa Martinez et al.   FREE RADICAL BIOLOGY AND MEDICINE

Factors associated with the presence of circulating active tissue factor and activated factor XI in stable angina patients

(2012) Michał Ząbczyk et al.   BLOOD COAGULATION & FIBRINOLYSIS

Fibrin Clot Structure and Function

(2011) Anetta Undas et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

A simple non-invasive diagnostic algorithm for ruling out chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism

(2011) F.A. Klok et al.   THROMBOSIS RESEARCH

Patient Outcomes after Acute Pulmonary Embolism

(2009) Frederikus A. Klok et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Isoprostanes and Lung Vascular Pathology

(2008) Luke J. Janssen   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY